Dr. Hippokratis Kiaris is an established investigator who is the PI for Center for Targeted Therapeutics Association,  Chatzistamou, I., Trimis, G., Frangou-Plemmenou, M., Pafiti-Kondi, A., & Kalofoutis, A. (2005, March 1). Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Research. Lafkas, D., Trimis, G., Papavassiliou, A. G., & Kiaris, H. (2008). p53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. International Journal of Cancer. Mihailidou, C., Chatzistamou, I., Papavassiliou, A., & Kiaris, H. (2015). Regulation of p21 during diabetes-associated stress of the endoplasmic reticulum. Endocrine-Related Cancer. Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., et al. (2012). Cyclin-dependant kinase 8 mediates damage-induced tumor-promoting paracrine activities. Proceedings of the National Academy of Sciences (109). Trimis, G., Chatzistamou, I., Politi, K., Kiaris, H., & Papavassiliou, A. G. (2008). Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Human Molecular Genetics(17).

Visit Program: https://naipi.org/south-eastern-regionhttps://naipi.org/2021/06/26/center-for-targeted-therapeutics//south-carolina/

South Carolina: https://naipi.org/south-eastern-region/south-carolina/